Global Montelukast Sodium Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at US$ 451 million in 2024 and is forecast to a readjusted size of USD 1032 million by 2031 with a CAGR of 12.7% during review period.
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.
This report is a detailed and comprehensive analysis for global Montelukast Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Montelukast Sodium market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Montelukast Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Montelukast Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Montelukast Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Montelukast Sodium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Montelukast Sodium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Montelukast Sodium market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Market segment by Application
Tablets
Chewable Tablet
Oral Solution
Major players covered
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Montelukast Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Montelukast Sodium, with price, sales quantity, revenue, and global market share of Montelukast Sodium from 2020 to 2025.
Chapter 3, the Montelukast Sodium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Montelukast Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Montelukast Sodium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Montelukast Sodium.
Chapter 14 and 15, to describe Montelukast Sodium sales channel, distributors, customers, research findings and conclusion.
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.
This report is a detailed and comprehensive analysis for global Montelukast Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Montelukast Sodium market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Montelukast Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Montelukast Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Montelukast Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Montelukast Sodium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Montelukast Sodium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Montelukast Sodium market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Market segment by Application
Tablets
Chewable Tablet
Oral Solution
Major players covered
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Montelukast Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Montelukast Sodium, with price, sales quantity, revenue, and global market share of Montelukast Sodium from 2020 to 2025.
Chapter 3, the Montelukast Sodium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Montelukast Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Montelukast Sodium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Montelukast Sodium.
Chapter 14 and 15, to describe Montelukast Sodium sales channel, distributors, customers, research findings and conclusion.
Table of Contents
134 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Montelukast Sodium by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
